Patient and health system factors associated with pretreatment loss to follow up among patients diagnosed with tuberculosis using Xpert® MTB/RIF testing in Uganda
Abstract Background In 2018, Uganda started only 65% of persons with incident tuberculosis on treatment. Pretreatment loss to follow up is an important contributor to suboptimal treatment coverage. We aimed to describe the patient and health facility-level characteristics associated with pretreatmen...
Main Authors: | Stella Zawedde-Muyanja, Achilles Katamba, Adithya Cattamanchi, Barbara Castelnuovo, Yukari C. Manabe |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-12-01
|
Series: | BMC Public Health |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12889-020-09955-0 |
Similar Items
-
The transition to Xpert MTB/RIF ultra: diagnostic accuracy for pulmonary tuberculosis in Kampala, Uganda
by: A. Andama, et al.
Published: (2021-01-01) -
Challenges with scale-up of GeneXpert MTB/RIF® in Uganda: a health systems perspective
by: Talemwa Nalugwa, et al.
Published: (2020-03-01) -
Use of XpertMTB/RIF for Mycobacterium tuberculosis identification
by: Roberto Deg'Innocenti, et al.
Published: (2014-12-01) -
Use of Xpert MTB/RIF for diagnosis of pediatric tuberculosis in Indonesia
by: Rina Triasih, et al.
Published: (2020-07-01) -
Application of CBNAAT (Xpert MTB/RIF assay) in new smear negative pulmonary tuberculosis patients
by: Vishal Chopra, et al.
Published: (2020-02-01)